A new study led by researchers at the University of Malaga proposes a new antiviral strategy against SARS-CoV-2—the virus ...
A pill called ensitrelvir is the first drug shown to effectively reduce infection after exposure to SARS-CoV-2.
RSV, and PIV are associated with a higher risk for acute respiratory failure, highlighting the need for increased monitoring and preventive interventions in hospitalized patients. Patients ...
UCSF researchers designed new drug candidates that potently block MPro, a viral enzyme that's crucial for SARS-CoV-2 replication. One of these drug candidates, AVI-4516, is shown (center) bound to the ...
In the article by Xie et al. (Aug. 8 issue) 1 regarding postacute sequelae of SARS-CoV-2 infection (PASC) in the pre-delta, delta, and omicron eras, the authors note that 71.89% of the decrease in ...
In a recent study published in the journal Cell and Bioscience, researchers investigated whether coffee has (inhibitory) effects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The U.S. Social Security Administration has requested the National Academies of Sciences, Engineering, and Medicine establish an ad hoc committee to review the diagnosis, treatment, and prognosis of ...